Private banks are shifting their allocations to Chinese stocks away from New York-traded ADRs towards those listed in Hong Kong and onshore, citing attractive valuations, supportive policy and less regulatory risk. The change comes as Chinese companies listed in the US face regulatory pressure, both from a looming drive to de-list these groups from American exchanges and a crackdown by…
Asia’s private banks cool on Chinese ADRs as de-listing threat grows
By Twinkle Sparta, senior reporter | 25 March 2022

Photo by Kirill Sharkovski on Unsplash
Share article
Share article
Related News

Is China facing its ‘Lehman moment’? Here’s what private banks think
27 July 2022

Chinese stocks to provide “bright spot in the stormy sea” in 2H22: UBS CIO
11 July 2022

Where now for beaten-down equities and bonds in 2H22? Private banks have their say
5 July 2022

Movers & Shakers – Private banks turn more selective as 2H22 looms
21 June 2022

How China’s 2022 growing pains are a headache for private banks
31 May 2022

Private banks unconvinced by China’s latest effort to boost property market
20 May 2022

Unfazed by tech rout, Chinese investors stick with home bias
17 May 2022

Credit Suisse goes overweight Chinese equities, sees “light at end of tunnel”
18 March 2022

Chinese equities pummeled by headwinds: PBs explain the stock market rout
16 March 2022

Noah says delisting pressure on ADRs presents “buying opportunities”, posts record revenue
15 March 2022